Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ala-Opas

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Urology|October 1, 1984
Five years of experience with selective therapy in recurrent calcium nephrolithiasisI Elomaa, M Ala-Opas, L Porkka
Spinal Cord|September 15, 2004
Bladder management in persons with spinal cord lesionA Dahlberg, I Perttilä, E Wuokko, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1987
Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stonesM Ala-Opas, I Elomaa, L Porkka, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Diagnostic problems associated with cystinuriaM Ala-Opas, I Sipilä, S Kivinen, et al.
European Urology|February 27, 2001
Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancerS Aaltomaa, P Lipponen, M Ala-Opas, et al.
Anticancer Research|July 1, 1996
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumourP Lipponen, S Vesalainen, J Kasurinen, et al.
European Urology|April 15, 2000
Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferationP Lipponen, S Aaltomaa, J Kellokoski, et al.
Abdominal Imaging|September 1, 1996
A primary carcinoid tumor of the kidney: a case report and review of the literatureS Kurl, H Rytkönen, P Farin, et al.
European Urology|January 1, 1997
Prognostic value of Ki-67 expression in renal cell carcinomasS Aaltomaa, P Lipponen, M Ala-Opas, et al.
The Prostate|April 30, 1999
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancerS Aaltomaa, P Lipponen, M Eskelinen, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Urology|October 1, 1984
Five years of experience with selective therapy in recurrent calcium nephrolithiasisI Elomaa, M Ala-Opas, L Porkka
Spinal Cord|September 15, 2004
Bladder management in persons with spinal cord lesionA Dahlberg, I Perttilä, E Wuokko, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1987
Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stonesM Ala-Opas, I Elomaa, L Porkka, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Diagnostic problems associated with cystinuriaM Ala-Opas, I Sipilä, S Kivinen, et al.
European Urology|February 27, 2001
Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancerS Aaltomaa, P Lipponen, M Ala-Opas, et al.
Anticancer Research|July 1, 1996
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumourP Lipponen, S Vesalainen, J Kasurinen, et al.
European Urology|April 15, 2000
Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferationP Lipponen, S Aaltomaa, J Kellokoski, et al.
Abdominal Imaging|September 1, 1996
A primary carcinoid tumor of the kidney: a case report and review of the literatureS Kurl, H Rytkönen, P Farin, et al.
European Urology|January 1, 1997
Prognostic value of Ki-67 expression in renal cell carcinomasS Aaltomaa, P Lipponen, M Ala-Opas, et al.
The Prostate|April 30, 1999
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancerS Aaltomaa, P Lipponen, M Eskelinen, et al.
Pageof 5